Zobrazeno 1 - 10
of 114
pro vyhledávání: '"M Brosa"'
Publikováno v:
Neurología (English Edition), Vol 29, Iss 4, Pp 210-217 (2014)
Introduction: At present, there is a lack of economic assessments of second-line treatments for relapsing-recurring multiple sclerosis. The aim of this study was to compare the efficiency between fingolimod and natalizumab in Spain. Methods: A cost m
Externí odkaz:
https://doaj.org/article/b26ee3e0e4c64275bdb2700bbdd404c6
Publikováno v:
Neurología, Vol 29, Iss 4, Pp 210-217 (2014)
Resumen: Introducción: Actualmente, existe una ausencia de evaluaciones económicas en el manejo de la esclerosis múltiple remitente-recurrente en segunda línea. El objetivo del trabajo fue comparar la eficiencia de fingolimod y natalizumab en Esp
Externí odkaz:
https://doaj.org/article/e553ac61abf549e7a93b446e43b6d65d
Autor:
M. Planas Vila, J. Álvarez Hernández, A. García de Lorenzo, S. Celaya Pérez, M. León Sanz, P. García-Lorda, M. Brosa
Publikováno v:
Nutrición Hospitalaria, Vol 25, Iss 6, Pp 1020-1024 (2010)
It is well known that hospital malnutrition is a highly prevalent condition associated to increase morbidity and mortality as well as related healthcare costs. Although previous studies have already measured the prevalence and/or costs of hospital nu
Externí odkaz:
https://doaj.org/article/786bbdef51b24c329877fa0d24356d3c
Autor:
Irene R. Dégano, Jean Ferrières, Christine Meisinger, Isaac Subirana, Ana Azevedo, Luigi Tavazzi, J. Marrugat, Rafael Ramos, J Blanch, Carles Forné, Marina Davoli, M Brosa, Eurotracs Investigators, Dimitrios Farmakis
Aims Percutaneous coronary intervention reduces mortality in acute coronary syndrome patients but the cost-utility of increasing its use in elderly acute coronary syndrome patients is unknown. Methods We assessed the efficiency of increased percutane
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f90fc0cdabc5813a5ab9e60f006447dd
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/80284
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/80284
Autor:
María Dolores Ibáñez, M Lluch-Bernal, A Navarro, M C Sánchez, Javier Montoro, Carmen Rondon, E Antón, M T Dordal, A Valero, M Brosa, Carlos Colás, V Matheu, B Fernández-Parra, Ignacio Dávila
Publikováno v:
Allergy. 72:959-966
Background Despite the socioeconomic importance of allergic rhinitis (AR), very few prospective studies have been performed under conditions of routine clinical practice and with a sufficiently long observation period outside the clinical trial scena
Publikováno v:
Value in Health
Objectives: Hospital Pharmacy Services have had to adapt their outpatient consultation services to introduce telepharmacy procedures because of the SARS-CoV-2 pandemic New methods of drug dispensation are explored to minimize risk of infection and op
Autor:
M. Brosa, V. Hernando
Publikováno v:
Value in Health
Objectives: More than 250,000 infected cases and 28,000 deaths have been reported in Spain associated to the COVID-19 pandemic The objective of this study was to quantify the burden of the COVID-19 in terms of Quality Adjusted Life Years (QALYs) loss
Publikováno v:
Value in Health. 23:S686
Autor:
Dimitrios Farmakis, J. Marrugat, Jean Ferrières, Inge Kirchberger, Luigi Tavazzi, M Brosa, Eurotracs, I Roman Degano, Carles Forné
Publikováno v:
European Heart Journal. 39
Publikováno v:
Value in Health. 22:S855-S856